New Zealand markets closed

Catalent, Inc. (CTLT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
132.73+0.42 (+0.32%)
At close: 4:03PM EDT
132.73 0.00 (0.00%)
After hours: 04:20PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close132.31
Bid132.76 x 900
Ask132.39 x 3200
Day's range131.79 - 133.00
52-week range86.43 - 142.64
Avg. volume853,354
Market cap22.678B
Beta (5Y monthly)1.39
PE ratio (TTM)42.68
EPS (TTM)3.11
Earnings date02 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est150.92
  • Business Wire

    Catalent, Inc. Announces First Quarter Fiscal Year 2022 Earnings Conference Webcast

    SOMERSET, N.J., October 20, 2021--Catalent, Inc. (NYSE: CTLT), the leading global provider of development sciences and manufacturing platforms for medicines, including biotherapeutics; cell and gene therapies; and consumer health products, today announced that it will release financial results for the first quarter of fiscal year 2022 ended September 30, 2021, before the market open on Tuesday, November 2, 2021. The Company’s management will host a webcast to discuss the results at 8:15 a.m. ET

  • Zacks

    3 Reasons to Add Catalent (CTLT) Stock to Your Portfolio

    Investors continue to be optimistic about Catalent (CTLT) owing to its slew of strategic deals and product launches.

  • Zacks

    Catalent (CTLT) Expands Presence in Japan Via New Facility

    Catalent's (CTLT) new site is expected to become a key hub in its Asia-Pacific Clinical Supply Services network by significantly boosting its business.